Abridge
B2B enterprise SaaS. Per-clinician annual subscription (~$2,500/clinician/yr, list) sold directly to health systems and academic medical centers; deep native integration ('Abridge Inside') with Epic; expanding from documentation into revenue-cycle coding and inpatient workflows ('care intelligence').
Valuation ~3.2x from $0.85B (Feb 2024) to $2.75B (Feb 2025), then ~2x again to $5.3B (Jun 2025) in ~4 months; the reported Apr 2026 extension held the $5.3B mark rather than marking up. Series C valuation and the Apr 2026 extension are reported figures, not company-confirmed audited data.
Where our coverage leans
Sign in free to read the bull & bear take — Pro unlocks the full dossier.
Full financial intelligence for Abridge
Earnings, margins & COGS, the income-statement breakdown, SWOT, moats & dependencies, the supplier–customer ecosystem graph, top signals & trends, and the valuation range.
- Income statement & margin structure
- SWOT, moats & dependency map
- Supplier–customer ecosystem graph
- Signals, trends & valuation range